
The efficacy of tumor marker screening for occult malignancies in patients with thromboembolic disease is generally limited. Extensive screening has not shown additional benefits over limited or standard screening methods concerning mortality and clinical outcomes.
thromboembolic disease, tumor markers, diagnosis, screening, efficacy, oncology, haematology, occult malignancies
thromboembolic disease, tumor markers, diagnosis, screening, efficacy, oncology, haematology, occult malignancies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
